Jebrane Bouaoud

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan et al. · Journal for ImmunoTherapy of Cancer · 2022 · 69 citations · Full text

Medicine, Immunology, Oncology +17

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · European Journal of Cancer · 2022 · 66 citations

Life Sciences, Immunology, Oncology +17

DIVA, a 3D virtual reality platform, improves undergraduate craniofacial trauma education

Jebrane Bouaoud, Mohamed El Beheiry, Eve Jablon et al. · Journal of Stomatology Oral and Maxillofacial Surgery · 2020 · 38 citations

Education, Educational Technology, Maxillofacial Surgery +14

Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival

Jebrane Bouaoud, Jean‐Philippe Foy, Antonin Tortereau et al. · OncoImmunology · 2021 · 37 citations · Full text

Medicine, Immunology, Oncology +17

CDYL2 Epigenetically Regulates MIR124 to Control NF-κB/STAT3-Dependent Breast Cancer Cell Plasticity

Maha Siouda, Audrey D. Dujardin, Laetitia Barbollat‐Boutrand et al. · iScience · 2020 · 35 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17